TuesdayNov 21, 2017 8:30 am

Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products

Announces formation of new Canadian subsidiary Ovation Science Inc. Agreement forged with Lighthouse Strategies, LLC, regarding exclusive use of patented topical and transdermal formulations in select U.S. markets Licensing agreement recently made with Canopy Growth Corp. for exclusive rights in Canada Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC (http://cnw.fm/6HjR4). The agreement, made through Ovation, stipulates that Lighthouse will have exclusive use of the company’s patented topical and transdermal formulations for select…

Continue Reading

ThursdayNov 16, 2017 3:31 pm

ChineseInvestors.com, Inc. (CIIX) Launches OptHemp Line Through Its Subsidiary, ChineseHempOil.com On Amazon.com (NASDAQ: AMZN) For Singles Day 2017

Readies debut of two more new products on Amazon prior to Black Friday and Cyber Monday Company has a strategic partnership with a Top 100 platinum level seller-partner with Amazon Marketplace The New York Times: Alibaba generated record sales of $25.3 billion on Singles Day 2017 ChineseInvestors.com, Inc. (OTCQB: CIIX), through its subsidiary ChineseHempOil.com, Inc., has launched its OptHemp product Line on Amazon.com (NASDAQ: AMZN) for the 2017 Singles Day promotion. It was debuted during a multi-channel campaign for both the U.S. and Chinese-American markets during the 9th annual Singles Day in China, the company announced (http://cnw.fm/4Pdqi). The New York Times…

Continue Reading

ThursdayNov 16, 2017 9:00 am

Meteoric Rise of Bitcoin, Open Embracing of Blockchain by Sector Majors

CBDWire Editorial Coverage: The price of bitcoin recently hit an all-time high of more than $7,800, edging closer to Goldman Sachs’ (NYSE: GS) forecast that the cryptocurrency will hit $8,000. This projection echoes increasing interest and application for cryptocurrency, as demonstrated by several public companies such as high-tech payment processing solutions provider SinglePoint, Inc. (SING) (SING Profile), which stands at the nexus of two roaring industries: cryptocurrency and cannabis. The widespread applicability of blockchain technology to multiple industries, combined with investor’s insatiable appetite for bitcoin and other cryptocurrencies, has also lit a fire under sector players Bitcoin Investment Trust (GBTC),…

Continue Reading

TuesdayNov 14, 2017 3:50 pm

Medical Cannabis Payment Solutions (REFG) Offers Cannabis Retailers Merchant Processing They Can Bank On

Medical marijuana now legal in 30 U.S. jurisdictions Comprehensive merchant processing solution dedicated to marijuana industry Frees customers and retailers from solely using cash The Controlled Substances Act (CSA), signed into law by President Richard Nixon in 1970, continues to cast a baneful shadow over the liberalization landscape. In the half a century since its passage, public attitudes toward cannabis have changed. A survey conducted by the respected Pew Research Center late last year found that ‘57% of U.S. adults say the use of marijuana should be made legal’ (http://cnw.fm/aTFj9). This is up from 12% in 1969, the year before…

Continue Reading

MondayNov 13, 2017 3:34 pm

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Driving Cannabis Costs Down While Meeting Patient Needs

Strong cash position of over $40 million to fund aggressive expansion timeline One of first companies to obtain cannabis production license from Health Canada Infrastructure in place to take advantage of projected $9 billion Canadian cannabis market Sees ample opportunities in Western Europe with first marketing push in Germany Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited. Abcann’s approach to growing cannabis centers on replicating the natural environment of any geographical location for a product…

Continue Reading

MondayNov 13, 2017 11:46 am

Marijuana Company of America, Inc. (MCOA) Offers Portfolio of Promise in Cannabis and Hemp

Global cannabis market to hit $31 billion by 2021 Diverse portfolio positioned along the cannabis and hemp value chains Completed financing for 30,000 sq. ft. greenhouse cultivation facility Wholly-owned subsidiary hempSMART™ currently has CBD-based wellness products available for sale A new report from market analyst the Brightfield Group, featured in Forbes (http://cnw.fm/ii9FL), estimates that global sales of cannabis will climb to $31.4 billion by 2021. The U.S., which “currently drives 90 percent of global cannabis sales,” will dominate this international business. In turn, a large share of the U.S. cannabis market will undoubtedly go to one of the six biggest…

Continue Reading

MondayNov 13, 2017 8:54 am

Medical Cannabis Payment Solutions (REFG) is “One to Watch”

Pioneered comprehensive card processing payment operation dedicated to medical marijuana industry Proprietary merchant processing system serves demands of the legal $6 billion cannabis market Alternative payment solution empowers businesses by tracking sales and tax collection, frees consumers and retailers from solely using cash Fully compliant with FinCEN’s anti-money laundering efforts Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales…

Continue Reading

FridayNov 10, 2017 11:42 am

ChineseInvestors.com, Inc. (CIIX) Gains from Explosive Investor Relations Division Growth

Investor Relations operations revenues jumped 186% in 1Q2018, driven by expanded program offerings, such as CIIX’s multi-media and presentations in roadshows customized to help clients build their brands CIIX also receives new revenue from consumer product sales of its hemp-based line generated by a company subsidiary formed in early 2017 Company had 76% YOY boost in operating sales in fiscal 2017; sets FY2018 goal of greater than 100% increase in sales, lower costs, and profitability ChineseInvestors.com, Inc. (OTCQB: CIIX) is driving revenue growth from its Investor Relations Division, realizing a 186% jump in sales for 1QFY2018. The first quarter revenue…

Continue Reading

WednesdayNov 08, 2017 3:30 pm

Grey Cloak Tech, Inc. (GRCK) to Debut CannaBio Salve in Las Vegas at MJBizCon, November 14-17, through Subsidiary Eqova Life Sciences

Clinical-grade salve is designed for topical skin use and contains full spectrum hemp oil, menthol, and essential oils; it is developed to treat minor skin irritations and tight or sore muscles Eqova will distribute salve to patients through licensed health practitioners Marijuana Business Conference (MJBizCon) is the industry’s premier and largest trade show, generating for Eqova an audience of potentially thousands of cannabis-related executives Grey Cloak Tech, Inc. (OTCQB: GRCK), through subsidiary Eqova Life Sciences, will introduce CannaBio Salve at the Marijuana Business Conference (MJBizCon), to be held November 14-17 in Las Vegas (http://cnw.fm/GvJ7i). Per the announcement, it is the…

Continue Reading

WednesdayNov 08, 2017 2:41 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners

High-margin licensing royalties of 5-10% of gross sales of its patented bioscience technology and process are an attractive valuation builder; LXRP sees more licensing opportunities in 2018 LXRP’s technology is patented in the U.S. and Australia; company has national/regional filings pending in 44 countries Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners. LXRP has also expanded its process of improved and faster inhalation by the body of fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) in pain…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722